This system helps consumers and patients instantly verify the source of a purchased pharmaceutical free of cost, at the point of purchase, using standard mobile phones.

Launched in 2007, the mPedigree initiative actively engages stakeholders in developing nations towards safer drugs via a combination of stepped up enforcement and carefully crafted technology.

MPedigree's efforts contribute directly in developing a comprehensive strategy to combat fake drugs in developing nations, where the WHO estimates that more than 30 per cent of drugs are spurious.

Through cellular authentication methods, mPedigree has validated the concept of mobile-based drug pedigree assurance in developing nations.

Bright B. Simons is the chief strategist of the company.

Image: mPedigree initiative. | Photograph, courtesy: mPedigree

Also read: This IIT-ian has dedicated his life to rural folk

Back

Next